Used in the synthesis of SGLT2 inhibitors for diabetes treatment. Acts as an intermediate in producing antihyperglycemic agents that help lower blood glucose levels by preventing glucose reabsorption in the kidneys. Commonly employed in pharmaceutical development for type 2 diabetes drugs due to its structural specificity and bioavailability enhancement when deacetylated. Also utilized in research settings to explore new analogs with improved metabolic stability and potency.